Investigating the effects of cannabinoids for the reduction of inflammation and sickle cell disease pain (CRISP); A protocol for a randomized double-blind placebo-controlled study
Sickle Cell Disease (SCD) is a hemoglobinopathy affecting millions of people globally. Pain, both acute and chronic, affects over half of those living with SCD, but treatment of chronic pain is an ongoing challenge. While opioid treatments are widely used for…
Citation: Bellis J, Monk L, Jhawar R, Pollock G, Liu A, Jacobs-McFarlane C, et al. (2026) Investigating the effects of cannabinoids for the reduction of inflammation and sickle cell disease pain (CRI…